Drug development
Celcuity develops cancer drugs, with most of its work centered on advancing gedatolisib through clinical trials and regulatory steps.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Celcuity Inc. is a clinical-stage biotechnology company that develops cancer drugs aimed at specific tumor signaling pathways. Its main work is to identify which patients are most likely to respond to a treatment and then advance drugs that block the biological signals helping cancer cells grow. The company’s lead programs are built around targeted therapies rather than broad chemotherapy, so its business depends on matching the right drug to the right cancer biology.
Celcuity does not sell a wide range of commercial medicines. It makes money mainly through drug development activities, which can include licensing, collaboration payments, and future product sales if its candidates win approval. Its research platform is used to study patient tumor samples and help guide clinical trial design, which gives the company a role both as a drug developer and as a precision-medicine toolmaker.
For investors, the key point is that Celcuity sits in the high-risk, high-reward part of biotech. It is trying to turn lab and clinical data into approved cancer treatments that address patients with specific molecular markers. That makes its business model different from a traditional drugmaker: most of its value depends on successful clinical testing, regulatory approval, and eventual adoption by oncologists and hospitals.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more